Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Platelet binding studies in panic disorder.

D J Nutt, S Fraser

    Journal of Affective Disorders
    |January 1, 1987
    PubMed
    Summary
    This summary is machine-generated.

    Platelet alpha 2-adrenoceptor and serotonin transporter binding sites were analyzed in panic disorder patients. No significant differences in these binding parameters were observed compared to healthy controls.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Human brain changes after first psilocybin use.

    Nature communications·2026
    Same author

    Ultra-Sensitive Detection of <i>Phytophthora pluvialis</i> by Real-Time PCR Targeting a Mitochondrial Gene.

    Phytopathology·2025
    Same author

    Serotonergic psychedelics for depression: A comprehensive overview.

    International review of neurobiology·2025
    Same author

    Suicidal Ideation in Medicinal Cannabis Patients: A 12-Month Prospective Study.

    Archives of suicide research : official journal of the International Academy for Suicide Research·2024
    Same author

    Psilocybin and Other Classic Psychedelics in Depression.

    Current topics in behavioral neurosciences·2023
    Same author

    Canalization and plasticity in psychopathology.

    Neuropharmacology·2022
    Same journal

    Consensus by design: Conflict of interest and the intravenous ketamine Delphi guidelines.

    Journal of affective disorders·2026
    Same journal

    Impaired crying despite preserved emotional experience under antidepressant treatment: An under-recognized clinical phenomenon.

    Journal of affective disorders·2026
    Same journal

    Corrigendum to "Effects of neuronavigation-guided rTMS on serum BDNF, TrkB and VGF levels in depressive patients with suicidal ideation" [J. Affect. Disord. 323 (2023) 617-623].

    Journal of affective disorders·2026
    Same journal

    Transcutaneous vagus nerve stimulation enhances reward-effort efficiency in severe major depressive disorder.

    Journal of affective disorders·2026
    Same journal

    Age-varying associations between attitudes toward suicide and suicidal ideation in Chinese psychiatric outpatients.

    Journal of affective disorders·2026
    Same journal

    Aripiprazole once-monthly for patients diagnosed with bipolar I disorder: Number needed to treat, number needed to harm, and likelihood to be helped or harmed.

    Journal of affective disorders·2026
    See all related articles

    Area of Science:

    • Neuroscience
    • Psychiatry
    • Pharmacology

    Background:

    • Panic disorder is a psychiatric condition characterized by recurrent, unexpected panic attacks.
    • Previous research suggested potential alterations in platelet receptor binding in mood disorders, including depression.
    • The role of specific neurotransmitter systems, such as adrenergic and serotonergic pathways, is implicated in anxiety disorders.

    Purpose of the Study:

    • To investigate the binding characteristics of alpha 2-adrenoceptors and serotonin (5-HT) uptake sites on intact platelets from patients diagnosed with panic disorder.
    • To compare these binding parameters with those of an age- and sex-matched healthy control group.
    • To explore the implications of findings in relation to reported platelet binding abnormalities in depression.

    Main Methods:

    Related Experiment Videos

    • Radioligand binding assays were employed using [3H]yohimbine for alpha 2-adrenoceptors and [3H]imipramine for 5-HT uptake sites.
    • Measurements were conducted on intact platelets obtained from 15 patients with a DSM-III diagnosis of panic disorder.
    • Data were compared against a control group matched for age and sex.

    Main Results:

    • No statistically significant differences were found in the maximum number of binding sites (Bmax) for either alpha 2-adrenoceptors or 5-HT uptake sites between panic disorder patients and controls.
    • Similarly, no significant differences in the dissociation constant (Kd), reflecting receptor affinity, were observed for either binding site.
    • The binding parameters for both investigated sites remained comparable between the patient and control groups.

    Conclusions:

    • The study did not find evidence of altered alpha 2-adrenoceptor or serotonin transporter binding on platelets in patients with panic disorder.
    • These findings suggest that platelet alpha 2-adrenoceptor and 5-HT uptake sites may not be primary biological markers for panic disorder.
    • The results contrast with some reports of platelet binding abnormalities in depression, indicating potential differences in the neurobiological underpinnings of these conditions.